Evidence map›Paper›PMID 10233052›Full record

ArticleBiophysical journal1999

Improved secondary structure predictions for a nicotinic receptor subunit: incorporation of solvent accessibility and experimental data into a two-dimensional representation.

N Le Novère, P J Corringer, J P Changeux

Abstract readComparative Study
In one paragraph

Article in Biophysical journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2015
    Review
  5. Article
  6. Functional prokaryotic-eukaryotic chimera from the pentameric ligand-gated ion channel family.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  7. Article
  8. Article
  9. Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  18. Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  19. Article
  20. A method for soluble overexpression of the alpha7 nicotinic acetylcholine receptor extracellular domain.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N Le NovèreCentre National de la Recherche Scientifique URA D1284 Neurobiologie Moléculaire, Institut Pasteur, 75015 Paris, France. lenov@pasteur.fr
P J Corringer
J P Changeux

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abstract A refined prediction of the nicotinic acetylcholine receptor (nAChR) subunits' secondary structure was computed with third-generation algorithms. The four selected programs, PHD, Predator, DSC, and NNSSP, based on different prediction approaches, were applied to each sequence of an alignment of nAChR and 5-HT3 receptor subunits, as well as a larger alignment with related subunit sequences from glycine and GABA receptors. A consensus prediction was computed for the nAChR subunits through a "winner takes all" method. By integrating the probabilities obtained with PHD, DSC, and NNSSP, this prediction was filtered in order to eliminate the singletons and to more precisely establish the structure limits (only 4% of the residues were modified). The final consensus secondary structure includes nine alpha-helices (24.2% of the residues, with an average length of 13.9 residues) and 17 beta-strands (22.5% of the residues, with an average length of 6.6 residues). The large extracellular domain is predicted to be mainly composed of beta-strands, with only two helices at the amino-terminal end. The transmembrane segments are predicted to be in a mixed alpha/beta topology (with a predominance of alpha-helices), with no known equivalent in the current protein database. The cytoplasmic domain is predicted to consist of two well-conserved amphipathic helices joined together by an unfolded stretch of variable length and sequence. In general, the segments predicted to occur in a periodic structure correspond to the more conserved regions, as defined by an analysis of sequence conservation per position performed on 152 superfamily members. The solvent accessibility of each residue was predicted from the multiple alignments with PHDacc. Each segment with more than three exposed residues was assumed to be external to the core protein. Overall, these data constitute an envelope of structural constraints. In a subsequent step, experimental data relative to the extracellular portion of the complete receptor were incorporated into the model. This led to a proposed two-dimensional representation of the secondary structure in which the peptide chain of the extracellular domain winds alternatively between the two interfaces of the subunit. Although this representation is not a tertiary structure and does not lead to predictions of specific beta-beta interaction, it should provide a basic framework for further mutagenesis investigations and for fold recognition (threading) searches.

Indexed as

AlgorithmsAmino Acid SequenceAnimalsBinding SitesBiophysical PhenomenaBiophysicsComputer SimulationLigandsModels, MolecularMolecular Sequence DataProtein ConformationProtein Structure, SecondaryReceptors, NicotinicSequence Homology, Amino AcidSoftwareSolventsLigandsReceptors, NicotinicSolvents

Identifiers

PMID10233052
PMCPMC1300207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.